Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In the absence of HLA-C*06:02, an ERAP1 haplotype of low activity was conducive to psoriasis if a functional ERAP2 allele was present, but the same ERAP1 haplotype was protective if the ERAP2 allele was defective.
|
29183862 |
2018 |
Psoriasis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
No differential expression of ERAP1 was observed either between paired uninvolved and involved skin tissues of psoriasis patients or between non-risk and risk variants in the involved skin.
|
28867178 |
2017 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.
|
26974007 |
2016 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
It was found that single nucleotide polymorphisms (SNPs) of endoplasmic reticulum aminopeptidase (ERAP1 and ERAP2) genes influence the risk of ankylosing spondylitis, the most common form of SpA and the risk of psoriasis.
|
28083616 |
2016 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants and haplotypes of ERAP1 are associated with AS, psoriasis, and Behçet's disease in people of varying ancestries.
|
26002026 |
2015 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis.
|
25854761 |
2015 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Moreover, we need to determine allele-specific effects of ERAP1 variants in the context of HLA-B*51 and HLA-Cw*6, which are associated with Behçet's disease and psoriasis, respectively.
|
26002027 |
2015 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.
|
25574825 |
2015 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
CTD_human |
We discovered two independent missense SNVs in IL23R and GJB2 of low frequency and five common missense SNVs in LCE3D, ERAP1, CARD14 and ZNF816A associated with psoriasis at genome-wide significance.
|
24212883 |
2014 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
BEFREE |
We discovered two independent missense SNVs in IL23R and GJB2 of low frequency and five common missense SNVs in LCE3D, ERAP1, CARD14 and ZNF816A associated with psoriasis at genome-wide significance.
|
24212883 |
2014 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Psoriasis severity was associated with the single nucleotide polymorphisms tagging IFIH1 and ERAP1 (p < 0.05).
|
24791935 |
2014 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I-ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behçet's disease.
|
23291587 |
2013 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I-ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behçet's disease.
|
23291587 |
2013 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
ERAP1 single-nucleotide polymorphism rs26653, which, to our knowledge, has not previously been reported in psoriasis, is nonsynonymous, has suggestive functional consequences, and herein displays strong association with disease.
|
22931917 |
2013 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Using a two-stage case-control design, we searched for pairwise interactions between cigarette smoking and alcohol intake respectively with 9 single nucleotide polymorphisms (SNPs) at ERAP1, PTTG1, CSMD1, GJB2, SERPINB8, ZNF816A and TNIP1/ANXA6 that have been associated with risk for psoriasis in 7,223 subjects.
|
23541940 |
2013 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Notably, one additional psoriasis-associated variant, rs27524 (5q15, ERAP1), showed evidence of an association with cHL in the genome-wide association study (OR = 1.21, 95% CI = 1.10 to 1.33, P = 1.5 × 10(-4)) and replication series (P = .03).
|
22286212 |
2012 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
|
23143594 |
2012 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Similar to AS, the strongest genetic signal of susceptibility to psoriasis and psoriatic arthritis also emanates from the MHC region (attributable mostly to HLA-C(*)06:02 although other genes have been implicated), and gene-gene interaction of HLA-C with ERAP1.
|
22487796 |
2012 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Paediatric-onset psoriasis showed a significant association with single nucleotide polymorphisms in the ERAP1 (P = 0.042) and IL23R loci (P = 0.042), LCE3C_LCE3B-del (P = 0.003) and HLA-C*06 (P = 1.72 × 10(-19)) when compared with the control group.
|
22512642 |
2012 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
|
23143594 |
2012 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in ERAP1 have been associated with chronic inflammatory diseases, including ankylosing spondylitis (AS) and psoriasis, and subsequent in vitro enzyme studies suggest distinct catalytic properties of ERAP1 variants.
|
21508329 |
2011 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
BEFREE |
ERAP1 and ZNF816A were associated with type 1 (early onset) psoriasis in the Chinese Han population (test for heterogeneity P = 6.5 × 10⁻³ and P = 1.5 × 10⁻³, respectively).
|
20953187 |
2010 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
CTD_human |
ERAP1 variants only influenced psoriasis susceptibility in individuals carrying the HLA-C risk allele.
|
20953190 |
2010 |
Psoriasis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
ERAP1 variants only influenced psoriasis susceptibility in individuals carrying the HLA-C risk allele.
|
20953190 |
2010 |
Psoriasis
|
0.500 |
Biomarker
|
disease |
CTD_human |
ERAP1 and ZNF816A were associated with type 1 (early onset) psoriasis in the Chinese Han population (test for heterogeneity P = 6.5 × 10⁻³ and P = 1.5 × 10⁻³, respectively).
|
20953187 |
2010 |